Subscribe to Newsletter

Subspecialties

Subspecialties Refractive

Ctrl + Shift + IOL

| Roisin McGuigan

Controlling for myopic shift following cataract surgery in infants: too many variables?

Subspecialties Basic & Translational Research

Benchmarking Dry AMD

| Roisin McGuigan

What does analysis of the last five years of dry AMD literature tell us about the field?

Subspecialties Business and Innovation

The Bot that Busts Clots

| Ruth Steer

A world first: clinical use of a robot for retinal vein cannulation.

Subspecialties Refractive

Too Soon to SMILE

| Julian Stevens

Despite the emerging alternatives, femto LASIK remains at the cutting edge of vision correction.

Subspecialties Other

Tears of Blood

| Mark Hillen

Are new ocular anticoagulants more or less likely than warfarin to cause intraocular bleeding?

Subspecialties Basic & Translational Research

Long Live the Stem Cell!

| Ruth Steer

Why don't stem cells survive in the eye? A new study sheds some light on the subject…

Subspecialties Business and Innovation

Mouse Versus Monkey

| Roisin McGuigan

New AAV vectors promise better cell type targeting in mice - but does this hold up in primates?

Subspecialties Cataract

Beyond Bifocals

In conversation with Thomas Kohnen during the Alcon Multifocal IOL User Meeting in Prague, June 2016

Subspecialties Glaucoma

A Long Term Look at CLASS

| Noa Geffen

The 5-year trial results are in. How safe and effective is the CLASS procedure?

Subspecialties Glaucoma

A User's Guide to SLT

| Dan Lindfield

What benefits can SLT offer, and which patients are eligible?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: